| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc | EVP and COO | Ordinary Shares | 525K | $16.4K | $0.03 | May 18, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RVLP | RVL Pharmaceuticals plc | May 18, 2023 | 1 | -$4.85K | 4 | May 22, 2023 | EVP and COO |
| RVLP | RVL Pharmaceuticals plc | Jan 24, 2023 | 1 | -$12.1K | 4 | Jan 26, 2023 | EVP and COO |
| RVLP | RVL Pharmaceuticals plc | Aug 8, 2022 | 1 | $233K | 4 | Aug 9, 2022 | EVP and COO |
| RVLP | RVL Pharmaceuticals plc | May 18, 2022 | 1 | -$8.78K | 4 | May 20, 2022 | EVP and COO |
| RVLP | RVL Pharmaceuticals plc | Jan 24, 2022 | 1 | -$10.9K | 4 | Jan 26, 2022 | EVP and COO |
| RVLP | Osmotica Pharmaceuticals plc | Dec 16, 2021 | 1 | $100K | 4 | Dec 20, 2021 | EVP and COO |
| RVLP | Osmotica Pharmaceuticals plc | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | EVP and COO |
| RVLP | Osmotica Pharmaceuticals plc | May 18, 2021 | 1 | -$20.7K | 4 | May 20, 2021 | EVP and COO |